A detailed history of Avidity Partners Management LP transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 5,026,000 shares of KZR stock, worth $2.71 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
5,026,000
Previous 5,026,000 -0.0%
Holding current value
$2.71 Million
Previous $4.52 Million 33.34%
% of portfolio
0.15%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.8 - $1.05 $436 - $573
546 Added 0.01%
5,026,000 $4.52 Million
Q4 2023

Feb 14, 2024

SELL
$0.72 - $1.15 $709,665 - $1.13 Million
-985,646 Reduced 16.4%
5,025,454 $4.77 Million
Q3 2023

Nov 14, 2023

SELL
$1.08 - $2.54 $74,412 - $175,006
-68,900 Reduced 1.13%
6,011,100 $7.15 Million
Q2 2023

Aug 14, 2023

SELL
$2.31 - $3.06 $1.02 Million - $1.34 Million
-439,400 Reduced 6.74%
6,080,000 $14.9 Million
Q1 2023

May 15, 2023

SELL
$3.13 - $7.31 $823,190 - $1.92 Million
-263,000 Reduced 3.88%
6,519,400 $20.4 Million
Q4 2022

Feb 14, 2023

BUY
$6.39 - $8.8 $8.74 Million - $12 Million
1,368,000 Added 25.27%
6,782,400 $47.7 Million
Q3 2022

Nov 14, 2022

BUY
$7.99 - $10.75 $10.9 Million - $14.7 Million
1,364,400 Added 33.69%
5,414,400 $46.6 Million
Q2 2022

Aug 15, 2022

BUY
$4.58 - $17.13 $2.44 Million - $9.11 Million
532,000 Added 15.12%
4,050,000 $33.5 Million
Q1 2022

May 16, 2022

BUY
$12.3 - $18.33 $3.56 Million - $5.31 Million
289,800 Added 8.98%
3,518,000 $58.5 Million
Q4 2021

Feb 14, 2022

BUY
$7.44 - $16.72 $22.1 Million - $49.6 Million
2,968,200 Added 1141.62%
3,228,200 $54 Million
Q3 2021

Nov 15, 2021

BUY
$4.85 - $9.73 $1.26 Million - $2.53 Million
260,000 New
260,000 $2.25 Million
Q2 2021

Aug 16, 2021

SELL
$4.93 - $6.46 $9.4 Million - $12.3 Million
-1,907,081 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.24 - $6.99 $9.99 Million - $13.3 Million
1,907,081 New
1,907,081 $11.4 Million

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $36.9M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.